Overview

Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan

Status:
Completed

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effectiveness and safety, over 3 months, of 4 dose regimens of CP-690,550, combined with methotrexate, for the treatment with active rheumatoid arthritis.

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Methotrexate
Tofacitinib